Skip to content
Reauthorization of federal seed funding, a top priority for BIO’s work with Congress, passed the House with hefty bipartisan support on March 17 and […]
SBIR reauthorization, a top BIO priority, is passed by Congress Read More »
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices Read More »
The Biotechnology Innovation Organization (BIO) hailed inclusion of a bill to encourage new treatments for children with rare diseases and measures targeting reform of
BIO lauds passage of PPRV reauthorization and legislation on PBM reform Read More »
The most notable differences between the pharmaceutical market in the U.S. and those in other countries are not in the prices. They’re in the
Pennsylvania is open for biotech business and working hard to grow the life sciences ecosystem that already exists in the state, according to Gov.
Pennsylvania’s Gov. Shapiro courts biotechs at BIO 2025 Read More »
Food and Drug Administration (FDA) Commissioner Martin A. Makary, M.D., M.P.H., sat down with the Biotechnology Innovation Organization (BIO) President and CEO John F.
BIO 2025: Commissioner Martin Makary, M.D., M.P.H., discusses vision for FDA Read More »
Public health advocates are reevaluating the vaccine landscape, revisiting long-held assumptions about vaccine policy during both public health emergencies and periods of relative calm.
BIO 2025: How do we talk about vaccines now? Read More »
To support and develop the world-leading biotech ecosystem of Massachusetts, Gov. Maura Healey puts a focus on people. Her work for biotech, which has
Gov. Healey, BIO Governor of the Year, boosts people to build biotech Read More »
Legislation introduced by Senators John Barrasso (R-WY) and Martin Heinrich (D-NM) would help protect the research and development of new treatments for patients with
Senators introduce bipartisan bill to protect new medicines for rare disease Read More »
Maintaining biotechnology superiority is essential to the U.S. economy and national security, and it must be supported with strategic federal funding that leans into
Congressional commission urges support in U.S.-China competition for biotech dominance Read More »
